vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $28.5M, roughly 1.0× Creative Media & Community Trust Corp). Outset Medical, Inc. runs the higher net margin — -67.5% vs -125.8%, a 58.3% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -2.0%). Over the past eight quarters, Outset Medical, Inc.'s revenue compounded faster (1.2% CAGR vs -8.5%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

CMCT vs OM — Head-to-Head

Bigger by revenue
OM
OM
1.0× larger
OM
$28.9M
$28.5M
CMCT
Growing faster (revenue YoY)
CMCT
CMCT
+5.6% gap
CMCT
3.6%
-2.0%
OM
Higher net margin
OM
OM
58.3% more per $
OM
-67.5%
-125.8%
CMCT
Faster 2-yr revenue CAGR
OM
OM
Annualised
OM
1.2%
-8.5%
CMCT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMCT
CMCT
OM
OM
Revenue
$28.5M
$28.9M
Net Profit
$-11.4M
$-19.5M
Gross Margin
42.4%
Operating Margin
-125.6%
-61.1%
Net Margin
-125.8%
-67.5%
Revenue YoY
3.6%
-2.0%
Net Profit YoY
-11.4%
24.0%
EPS (diluted)
$-3.89
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
OM
OM
Q4 25
$28.5M
$28.9M
Q3 25
$26.2M
$29.4M
Q2 25
$29.7M
$31.4M
Q1 25
$32.3M
$29.8M
Q4 24
$27.5M
$29.5M
Q3 24
$28.6M
$28.7M
Q2 24
$34.4M
$27.4M
Q1 24
$34.0M
$28.2M
Net Profit
CMCT
CMCT
OM
OM
Q4 25
$-11.4M
$-19.5M
Q3 25
$-12.5M
$-17.8M
Q2 25
$-9.0M
$-18.5M
Q1 25
$-6.1M
$-25.8M
Q4 24
$-10.3M
$-25.6M
Q3 24
$-10.4M
$-27.9M
Q2 24
$-796.0K
$-34.5M
Q1 24
$-3.7M
$-39.9M
Gross Margin
CMCT
CMCT
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
CMCT
CMCT
OM
OM
Q4 25
-125.6%
-61.1%
Q3 25
-47.7%
-53.7%
Q2 25
-30.3%
-53.7%
Q1 25
-19.0%
-55.1%
Q4 24
-128.8%
-74.2%
Q3 24
-36.9%
-83.2%
Q2 24
-1.6%
-112.3%
Q1 24
-10.7%
-131.0%
Net Margin
CMCT
CMCT
OM
OM
Q4 25
-125.8%
-67.5%
Q3 25
-47.5%
-60.6%
Q2 25
-30.3%
-59.0%
Q1 25
-18.9%
-86.7%
Q4 24
-129.8%
-87.0%
Q3 24
-36.3%
-97.5%
Q2 24
-2.3%
-125.8%
Q1 24
-11.0%
-141.8%
EPS (diluted)
CMCT
CMCT
OM
OM
Q4 25
$-3.89
$0.33
Q3 25
$-23.52
$-1.00
Q2 25
$-18.94
$-1.04
Q1 25
$-20.73
$-3.66
Q4 24
$97.71
$-7.21
Q3 24
$-305.04
$-8.02
Q2 24
$-98.64
$-9.96
Q1 24
$-125.46
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
OM
OM
Cash + ST InvestmentsLiquidity on hand
$15.4M
$168.9M
Total DebtLower is stronger
$509.8M
$96.2M
Stockholders' EquityBook value
$265.4M
$127.0M
Total Assets
$859.2M
$264.5M
Debt / EquityLower = less leverage
1.92×
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
OM
OM
Q4 25
$15.4M
$168.9M
Q3 25
$17.3M
$178.6M
Q2 25
$27.8M
$184.1M
Q1 25
$19.8M
$189.0M
Q4 24
$20.3M
$158.7M
Q3 24
$18.5M
$175.6M
Q2 24
$29.3M
$194.8M
Q1 24
$21.3M
$226.9M
Total Debt
CMCT
CMCT
OM
OM
Q4 25
$509.8M
$96.2M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
$197.4M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
OM
OM
Q4 25
$265.4M
$127.0M
Q3 25
$281.9M
$142.4M
Q2 25
$287.1M
$154.8M
Q1 25
$293.0M
$169.9M
Q4 24
$304.5M
$26.8M
Q3 24
$321.0M
$47.8M
Q2 24
$351.1M
$68.6M
Q1 24
$369.9M
$93.2M
Total Assets
CMCT
CMCT
OM
OM
Q4 25
$859.2M
$264.5M
Q3 25
$871.8M
$277.3M
Q2 25
$885.0M
$288.8M
Q1 25
$882.3M
$301.2M
Q4 24
$889.6M
$275.8M
Q3 24
$868.0M
$292.9M
Q2 24
$891.2M
$314.5M
Q1 24
$887.5M
$346.2M
Debt / Equity
CMCT
CMCT
OM
OM
Q4 25
1.92×
0.76×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
7.36×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
OM
OM
Operating Cash FlowLast quarter
$5.8M
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
OM
OM
Q4 25
$5.8M
$-9.5M
Q3 25
$3.7M
$-6.3M
Q2 25
$-2.5M
$-4.8M
Q1 25
$1.2M
$-25.7M
Q4 24
$17.0M
$-16.5M
Q3 24
$10.3M
$-20.6M
Q2 24
$3.9M
$-33.3M
Q1 24
$1.6M
$-45.9M
Free Cash Flow
CMCT
CMCT
OM
OM
Q4 25
$-9.7M
Q3 25
$-6.5M
Q2 25
$-5.1M
Q1 25
$-25.8M
Q4 24
$-16.5M
Q3 24
$-21.0M
Q2 24
$-33.5M
Q1 24
$-46.3M
FCF Margin
CMCT
CMCT
OM
OM
Q4 25
-33.7%
Q3 25
-22.0%
Q2 25
-16.3%
Q1 25
-86.7%
Q4 24
-56.1%
Q3 24
-73.1%
Q2 24
-122.2%
Q1 24
-164.3%
Capex Intensity
CMCT
CMCT
OM
OM
Q4 25
0.8%
Q3 25
0.5%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.1%
Q3 24
1.4%
Q2 24
0.4%
Q1 24
1.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCT
CMCT

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons